I agree that this site is using cookies. You can find further informations here.
X
Juliusson, G
139  results:
Search for persons X
?
1

P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST-LINE CYTAR..:

Jädersten, M. ; Lilienthal, I. ; Tsesmetzis, N....
HemaSphere.  6 (2022)  - p. 442-443 , 2022
Link: https://doi.org/10.1097/..
 
?
2

PCN203 HEALTH-CARE RESOURCE USE AND COSTS IN AML-PATIENTS U..:

Redig, J. ; Hernlund, E. ; Paulsson, B....
Value in Health.  22 (2019)  - p. S475 , 2019
Link: https://doi.org/10.1016/..
 
?
3

A platform for phenotypic discovery of therapeutic antibodi..:

Ljungars, A. ; Mårtensson, L. ; Mattsson, J....
npj Precision Oncology.  2 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
4

Early death rates remain high in high-risk APL: update from..:

Lehmann, S ; Deneberg, S ; Antunovic, P...
Leukemia.  31 (2017)  6 - p. 1457-1459 , 2017
Link: https://doi.org/10.1038/..
 
?
5

EGR2 mutations define a new clinically aggressive subgroup ..:

Young, E ; Noerenberg, D ; Mansouri, L...
Leukemia.  31 (2016)  7 - p. 1547-1554 , 2016
Link: https://doi.org/10.1038/..
 
?
6

An open-label phase I dose-finding study of APR-246 in hema..:

Deneberg, S ; Cherif, H ; Lazarevic, V...
Blood Cancer Journal.  6 (2016)  7 - p. e447-e447 , 2016
Link: https://doi.org/10.1038/..
 
?
7

Prevalence and characteristics of survivors from acute myel..:

for the Swedish AML Group and the Swedish Childhood Leukemia Group ; Juliusson, G ; Abrahamsson, J...
Leukemia.  31 (2016)  3 - p. 728-731 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Common variation at 12q24.13 (OAS3) influences chronic lymp..:

Sava, G P ; Speedy, H E ; Di Bernardo, M C...
Leukemia.  29 (2014)  3 - p. 748-751 , 2014
Link: https://doi.org/10.1038/..
 
?
9

Incidence and prognostic significance of karyotypic subgrou..:

Lazarevic, V ; Hörstedt, A-S ; Johansson, B...
Blood Cancer Journal.  4 (2014)  2 - p. e188-e188 , 2014
Link: https://doi.org/10.1038/..
 
?
10

FREQUENT GOOD PARTIAL REMISSIONS FROM THALIDOMIDE INCLUDING..:

Juliusson, G ; Celsing, F ; Turesson, I...
Journal of the Peripheral Nervous System.  5 (2000)  4 - p. 248-248 , 2000
Link: https://doi.org/10.1111/..
 
?
11

FREQUENT GOOD PARTIAL REMISSIONS FROM THALIDOMIDE INCLUDING..:

Juliusson, G ; Celsing, F ; Turesson, I...
Journal of the Peripheral Nervous System.  5 (2000)  4 - p. 248-248 , 2000
Link: https://doi.org/10.1046/..
 
?
12

Lenograstim (glycosylated rHuG-CSF) post high-dose chemothe..:

Björkstrand, B. ; Ljungman, P. ; Juliusson, G...
European Journal of Cancer.  35 (1999)  - p. S298 , 1999
Link: https://doi.org/10.1016/..
 
?
13

Lenograstim (glycosylated rHuG-CSF) enables mobilization of..:

Björkstrand, B. ; Ljungman, P. ; Villman, K...
European Journal of Cancer.  35 (1999)  - p. S297 , 1999
Link: https://doi.org/10.1016/..
 
?
14

Complications in the treatment of CLL with purine analogues:

Juliusson, G.
Hematology and Cell Therapy.  39 (1997)  S1 - p. S41-S44 , 1997
Link: https://doi.org/10.1007/..
 
?
15

Simvastatin impairs mitogen‐induced proliferation of malign..:

Vitols, S. ; Angelin, B. ; Juliusson, G.
Lipids.  32 (1997)  3 - p. 255-262 , 1997
Link: https://doi.org/10.1007/..
 
1-15